Similar Search Results

Acemoglu, Daron; Pischke, Jörn-Steffen - Centre for Economic Performance, LSE - 2002

Becker's theory of human capital predicts that minimum wages should reduce training investments for affected workers because they prevent these workers from taking wage cuts necessary to finance training. In contrast, in noncompetitive labor markets, minimum wages tend to increase training of...

Persistent link: https://www.econbiz.de/10005016812

Has Job Polarization Squeezed the Middle Class? Evidence from the Allocation of Talents

Boehm, Michael J. - Centre for Economic Performance, LSE - 2013

Over the last two decades, earnings in the United States increased at the top and at the bottom of the wage distribution but not in the middle - the intensely debated middle class squeeze. At the same time there was a substantial decline of employment in middle-skill production and clerical...

Persistent link: https://www.econbiz.de/10010652266

The Contribution of Pharmaceutical Innovation to Longevity Growth in Germany and France

Lichtenberg, Frank R. - 2014

I investigate the contribution of pharmaceutical innovation to recent longevity growth in Germany and France. First, I …-2006. The estimates imply that chemotherapy innovation accounted for at least one-sixth of the decline in French cancer …

Persistent link: https://www.econbiz.de/10013069689

Response to Baker and Fugh-Berman's Critique of My Paper, 'Why Has Longevity Increased More in Some States than in Others?'

Lichtenberg, Frank R. - 2009

innovation accounts for a substantial portion of recent increases in U.S. life expectancy. Baker and Fugh-Berman claim that my … literature. Baker and Fugh-Berman express deep skepticism about my study's conclusion that medical innovation has played a very …

Persistent link: https://www.econbiz.de/10013157847

Pharmaceuticai Innovation, Longevity, and Medical Expenditure in Greece, 1995-2010

Lichtenberg, Frank R. - 2021

Longitudinal, disease-level data are used to analyze the impact of pharmaceutical innovation on longevity (mean age at … pharmaceutical innovation increased mean age at death by 0.87 years (10.4 months) — about 44% of the total increase in longevity … pharmaceutical innovation. The baseline estimate of the cost per life-year gained from pharmaceutical innovation in Greece is $17 …

Persistent link: https://www.econbiz.de/10013315556

The Impact of Recent Chemotherapy Innovation on the Longevity of Myeloma Patients : U.S. and International Evidence

Lichtenberg, Frank R.; Hostenkamp, Gisela - 2021

important innovations since 1997. We investigate the impact of recent chemotherapy innovation on the longevity of myeloma … post-1997 chemotherapy innovation did not exceed $45,551. We also investigate the impact of chemotherapy innovation on the …, controlling for other factors. The estimates imply that chemotherapy innovation reduced the age-adjusted myeloma cancer mortality …

Persistent link: https://www.econbiz.de/10013315665

The Impact of Pharmaceutical Innovation on Longevity and Medical Expenditure in Sweden, 1997-2010 : Evidence from Longitudinal, Disease-Level Data

Lichtenberg, Frank R.; Pettersson, Billie - 2021

We use longitudinal, disease-level data to analyze the impact of pharmaceutical innovation on longevity and medical … expenditure in Sweden, where mean age at death increased by 1.88 years during the period 1997-2010. Pharmaceutical innovation is … the number of drugs to treat a disease, not the number of drug classes. Pharmaceutical innovation also reduced hospital …

Persistent link: https://www.econbiz.de/10013315886

Innovation Network

Acemoglu, Daron - 2016

linked fields. Our analysis uses 1.8 million U.S. patents and their citation properties to map the innovation network and its … strength. Past innovation network structures are calculated using citation patterns across technology classes during 1975 … predictive power on future innovation after 1995. This pattern is consistent with the idea that when there is more past upstream …

Persistent link: https://www.econbiz.de/10012977470

Innovation, Reallocation and Growth

Acemoglu, Daron; Akcigit, Ufuk; Bloom, Nicholas; Kerr, … - Centre for Economic Performance, LSE - 2013

We build a model of firm-level innovation, productivity growth and reallocation featuring endogenous entry and exit. A …

Persistent link: https://www.econbiz.de/10010655943